Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
life sciences
national blog main
national top stories
8
×
sanofi
8
×
boston top stories
clinical trials
san francisco blog main
biotech
new york blog main
deals
new york top stories
san francisco top stories
startups
alnylam pharmaceuticals
amgen
cancer
fda
ipo
new york
venture capital
boston
cancer drugs
inclisiran
investing
national
novartis
pcsk9
regeneron pharmaceuticals
revolution medicines
rna interference
san francisco
the column group
third rock ventures
vc
warp drive bio
abbvie
akili interactive labs
akouos
alirocumab
What
medicines
8
×
drug
announced
ipo
cancer
ceo
cholesterol
deal
disease
medco
medicine
new
proteins
research
revolution
targets
therapeutics
years
aces
acquire
acquisitions
address
adds
ago
agreed
allosteric
aren’t
backs
bets
big
billion
bio
brings
cancer’s
car
cash
click
clinic
collabs
company
Language
unset
Current search:
sanofi
×
medicines
×
" national top stories "
×
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
6 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”